Skip to main content

Furthering Animal Health

Contact Us
Research & Development

The animal health industry has been slow to make significant gains in R & D despite industry consolidation amongst global animal health companies. Kato will pursue collaborations and partnerships in Australia to ramp up its R & D productivity and pipeline.
Animal health

At Kato we cherish our pets and so our corporate focus will be on supporting veterinary practitioners and farmers by providing quality treatment for animals.
We will further animal health without compromising on quality and safety.

Welcome To Kato Laboratories

“Every new beginning comes from some other beginning’s end.” Seneca 4BC – 65AD

Welcome to Kato Laboratories, the beginning of a new enterprise for Tony McGloin, previously the owner and managing director of Apex Laboratories, a generic manufacturer of veterinary medicines in New South Wales, Australia. Dechra PLC acquired Apex in late 2016, thereby providing Tony with an opportunity to set out in a new direction, still in animal health, but with a greater focus on innovation.

Learn More

Australian

Australian premium wines, magnificent sandy beaches and the kangaroo are well known promoted products in the international arena that epitomise Australian quality, lifestyle and uniqueness. Less prominent is Australia’s high quality and safety record in the research, development and selling of animal medicines. The Australian APVMA’s code of good manufacturing practice (cGMP) for chemical products monitors quality assurance and company compliance under the Agvet Code Act 1994. This gives our customers and consumers confidence that all raw materials used in our products meet the required quality and purity standards.

Learn More